Clinical trials
Completed Hypercholesterolemia trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 9 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 18 |
| Sanofi | 6 |
| AstraZeneca | 2 |
| Pfizer | 2 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
| Kastle Therapeutics, LLC | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Universiteit Antwerpen | 1 |
| Université Catholique de Louvain | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 33 |
| Hyperlipidemias | 8 |
| Dyslipidemias | 5 |
| Homozygous Familial Hypercholesterolemia | 3 |
| Hyperlipoproteinemia Type II | 3 |
| Lipid Metabolism Disorders | 2 |
| Metabolic Diseases | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.